TABLE 3.
Stage II-III | Stage IV | ||||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95.0% CI | p | HR | 95.0% CI | p | ||||
ECOG PS | 3–4 vs. 0–2 | 6.138 | 1.212–31.075 | 0.028 | ECOG PS | 3–4 vs. 0–2 | 3.313 | 1.141–9.693 | 0.004 |
Surgery | Yes vs. no | 0.229 | 0.092–0.570 | 0.002 | Grade | III vs. I-II | 3.397 | 1.551–7.439 | 0.002 |
Stage | III vs. II | 3.195 | 1.111–9.183 | 0.031 | Liver metastasis | Yes vs. no | 2.537 | 1.134–5.672 | 0.023 |
Recurrence | Yes vs. no | 24.128 | 6.455–90.180 | <0.001 | CT vs. BSC | 0.156 | 0.069–0.348 | <0.001 |
CI: Confidence interval; CT: Chemotherapy; BSC: Best supportive care; ECOG PS: Eastern Cooperative Oncology Group Performance Status; HR: Hazard ratio.